NanoViricides, Inc. (NASDAQ:NNVC)

PRESS RELEASE

published on 12/23/2024 at 12:30, 1 year 7 months ago

NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
NanoViricides, Inc. announces that its antiviral drug candidate NV-387 shows promise in combating potential bird flu pandemic. The drug mimics essential host-side features, making it hard for the virus to escape

NanoViricides NV-387 Antiviral Drug H5N1 Bird Flu Pandemic
BRIEF

published on 11/15/2024 at 12:35, 1 year 8 months ago

NanoViricides Advances NV-387 to Phase II Trials for Multiple Viral Infections

NanoViricides NV-387 Financial Report Clinical Trials Antiviral Drug
BRIEF

published on 11/15/2024 at 12:35, 1 year 8 months ago

NanoViricides fait passer le NV-387 aux essais de phase II pour le traitement de multiples infections virales

NanoViricides NV-387 Rapport Financier Essais Cliniques Médicament Antiviral
PRESS RELEASE

published on 11/15/2024 at 12:30, 1 year 8 months ago

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID
NanoViricides, Inc. files Quarterly Report on Form 10-Q with the SEC, highlights financial results and progress on NV-387 antiviral drug for various infections including MPox and RSV

NanoViricides NV-387 Quarterly Report SEC Filing Antiviral Drug
BRIEF

published on 11/04/2024 at 06:05, 1 year 9 months ago

NanoViricides Presents at Spartan Capital Investors Conference 2024

NanoViricides NV-387 Antiviral Nanomedicines Spartan Capital Conference Dr. Anil R. Diwan
BRIEF

published on 11/04/2024 at 06:05, 1 year 9 months ago

NanoViricides présente sa nouvelle technologie à la conférence Spartan Capital Investors 2024

NanoViricides NV-387 Nanomédicaments Antiviraux Conférence Sur La Capitale Spartiate Dr Anil R. Diwan
PRESS RELEASE

published on 11/04/2024 at 06:00, 1 year 9 months ago

NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am
NanoViricides, Inc. to present corporate update at Spartan Capital Investors Conference on NV-387 antiviral drug development with strong market potential

NV-387 NanoViricides Inc. Market Potential Antiviral Drug Spartan Capital Investors Conference
BRIEF

published on 10/22/2024 at 12:35, 1 year 9 months ago

NanoViricides President to Present at PODD Conference

NanoViricides NV-387 Drug Delivery PODD Conference Antiviral Treatments
BRIEF

published on 10/22/2024 at 12:35, 1 year 9 months ago

Le président de NanoViricides fera une présentation à la conférence PODD

NanoViricides NV-387 Administration De Médicaments Conférence PODD Traitements Antiviraux
PRESS RELEASE

published on 10/22/2024 at 12:30, 1 year 9 months ago

NanoViricides President Dr. Diwan to Present at the PODD Conference
NanoViricides announces President Dr. Anil R. Diwan to speak at PODD Conference about revolutionary antiviral nanomedicines. Conference focuses on drug delivery partnerships and trends

NanoViricides Drug Delivery Antiviral Nanomedicines PODD Conference Anil R. Diwan

Published on 08/15/2026 at 00:50, 8 hours 25 minutes ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 9 hours ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 9 hours 30 minutes ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 9 hours 50 minutes ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 10 hours 15 minutes ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

Published on 08/15/2026 at 08:05, 1 hour 10 minutes ago

SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:29, 14 hours 46 minutes ago

Designated Persons Notifications
Published on 08/14/2026 at 18:29, 14 hours 46 minutes ago

Designated Persons Notifications
Published on 08/14/2026 at 18:15, 15 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 17 hours 10 minutes ago

GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON

View all EQS

Published on 08/13/2026 at 18:00, 1 day 15 hours ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 15 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 15 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 15 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 15 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE

News